Last reviewed · How we verify

NCT03822728

Intra-parotid Facial Nerve Imaging in Parotidectomy

Completed NA Last updated 27 November 2023
What this trial tests

NA trial testing 3D-DESS MRI (3 dimensional double echo steady state MRI) in Parotid Tumors in 270 participants. Completed in 31 July 2021.

Timeline
1 August 2017
Primary endpoint
31 July 2021
31 July 2021

Quick facts

Lead sponsorSamsung Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment270
Start date1 August 2017
Primary completion31 July 2021
Estimated completion31 July 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Samsung Medical Center

Who can join

Adults 18 to 70, any sex, with Parotid Tumors or Facial Nerve Paresis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators will evaluate the clinical usefulness of 3 dimensional double echo steady state MRI (3D-DESS MRI) for functional preservation of the facial nerve during parotidectomy. Preoperative 3D-DESS MRI imaging can provide information about the anatomical relationship between the tumor and the facial nerve in the parotid gland. Because the risk of postoperative facial weakness is relatively high in the deep-seated parotid tumors, the investigators will exclude the patients with the superficial parotid tumors (determined by preoperative CT or US) and only include the patients with deep seated parotid tumors in this trial. The main outcome of our study is the incidence of immediate postoperative facial weakness, and the secondary outcome is the incidence of facial weakness at postoperative 6 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Imaging of Facial Nerve With 3D-DESS-WE-MRI Before Parotidectomy: Impact on Surgical Outcomes.
    Jeong HS, Kim Y, Kim HJ, Kim HJ, et al · · 2023 · cited 12× · PMID 37634641 · DOI 10.3348/kjr.2022.0850

Verify or expand the search:

Other Samsung Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03822728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing